» Articles » PMID: 32725309

Clinical and Genetic Analysis of Cytochrome P450 Oxidoreductase (POR) Deficiency in a Female and the Analysis of a Novel POR Intron Mutation Causing Alternative MRNA Splicing : Overall Analysis of a Female with POR Deficiency

Overview
Publisher Springer
Date 2020 Jul 30
PMID 32725309
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To characterize the clinical features of a female with P450 oxidoreductase (POR) deficiency and to investigate the underlying mechanisms of POR inactivation.

Methods: The proband was a 35-year-old woman with primary infertility and menstrual irregularity. The reproductive endocrine profile was evaluated. DNA sequencing was conducted for the identification of POR gene mutation. RT-PCR was performed to confirm the impact of the mutation on POR mRNA. A molecular model was built for the structural analysis of mutant POR protein.

Results: The evaluation of reproductive endocrine profile revealed elevation of serum follicle-stimulating hormone (11.48 mIU/ml), progesterone (11.00 ng/ml), 17α-hydroxyprogesterone (24.24 nmol/l), dehydroepiandrosterone (6300 nmol/l), and androstenedione (3.89 nmol/l) and decreased estradiol (36.02 pg/ml). Sequencing of the POR gene showed the female was a compound heterozygote of the paternal P399_E401 deletion and a novel maternal IVS14-1G>C mutation. Functional analysis revealed IVS14-1G>C mutation caused alternative splicing of POR mRNA, with the loss of 12 nucleotides in exon 15 (c.1898_1909delGTCTACGTCCAG). Also, the resulting mutant POR protein had a V603_Q606 deletion, which inactivated the nucleotide-binding domain of NADPH in POR protein (K602_Q606).

Conclusion: The mutation IVS14-1G>C of the POR gene could cause alternative splicing of POR mRNA and dysfunction of the resulting POR protein. Under proper IVF strategy with glucocorticoid therapy and endometrial preparation, females with mild POR deficiency still have the opportunity to have a live birth.

Citing Articles

Diagnostic challenges and management advances in cytochrome P450 oxidoreductase deficiency, a rare form of congenital adrenal hyperplasia, with 46, XX karyotype.

Wang C, Tian Q Front Endocrinol (Lausanne). 2023; 14:1226387.

PMID: 37635957 PMC: 10453803. DOI: 10.3389/fendo.2023.1226387.


Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET.

Li Y, Zhang C, Zhang S Front Endocrinol (Lausanne). 2023; 13:1019696.

PMID: 36619579 PMC: 9813486. DOI: 10.3389/fendo.2022.1019696.


Getting pregnant with congenital adrenal hyperplasia: Assisted reproduction and pregnancy complications. A systematic review and meta-analysis.

Guo X, Zhang Y, Yu Y, Zhang L, Ullah K, Ji M Front Endocrinol (Lausanne). 2022; 13:982953.

PMID: 36120452 PMC: 9470834. DOI: 10.3389/fendo.2022.982953.


In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.

Nurhafizuddin M, Azizi A, Ming L, Shafqat N Molecules. 2022; 27(14).

PMID: 35889519 PMC: 9323898. DOI: 10.3390/molecules27144646.


Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature.

Gusmano C, Cannarella R, Crafa A, Barbagallo F, La Vignera S, Condorelli R J Endocrinol Invest. 2022; 46(1):1-14.

PMID: 35842891 PMC: 9829634. DOI: 10.1007/s40618-022-01849-9.


References
1.
Zavy M, Craig L, Wild R, Kahn S, OLeary D, Hansen K . In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. Reprod Biol Endocrinol. 2014; 12:119. PMC: 4258294. DOI: 10.1186/1477-7827-12-119. View

2.
Huang Y, Wang E, Du Q, Xiong Y, Guo X, Yu Y . Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages. Reprod Biol Endocrinol. 2015; 13:82. PMC: 4524365. DOI: 10.1186/s12958-015-0075-3. View

3.
Papadakis G, Dumont A, Bouligand J, Chasseloup F, Raggi A, Catteau-Jonard S . Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations. Hum Reprod. 2020; 35(4):939-949. DOI: 10.1093/humrep/deaa020. View

4.
Song T, Wang B, Chen H, Zhu J, Sun H . In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report. Gynecol Endocrinol. 2017; 34(5):385-388. DOI: 10.1080/09513590.2017.1393663. View

5.
Otto D, Henderson C, Carrie D, Davey M, Gundersen T, Blomhoff R . Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. Mol Cell Biol. 2003; 23(17):6103-16. PMC: 180925. DOI: 10.1128/MCB.23.17.6103-6116.2003. View